Fibronectin-Hepatocyte Growth Factor Enhances Reendothelialization in Tissue-Engineered Heart Valve
Takeyoshi Ota(University of Illinois Chicago), Yutaka Okita(Takatsuki General Hospital), Yoshiki Sawa(Osaka Police Hospital), Hikaru Matsuda(Osaka Health Science University), Takashi Kitajima(Otsuka (Japan)), Yuichiro Ueda(Medtronic (United States)), Chris Coppin(Medtronic (United States)), Shigemitsu Iwai(National Cerebral and Cardiovascular Center)
Cited by 54
Related Papers
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ
|European Journal of Cardio-Thoracic Surgery|2023|373
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
2021 The American Association for Thoracic Surgery expert consensus document: Surgical treatment of acute type A aortic dissection
|Journal of Thoracic and Cardiovascular Surgery|2021|344